Udvalget anbefalede udstedelse af markedsføringstilladelse for Dicural.
The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Dicural are greater than the risks for the treatment and recommended that Dicural be given a marketing authorisation.